Literature DB >> 16384802

Review of the literature on major mental disorders in adult patients with mitochondrial diseases.

Omar Fattal1, Kumar Budur, Aaron J Vaughan, Kathleen Franco.   

Abstract

Mitochondria are intracellular organelles crucial to the production cellular energy. Mitochondrial disease results from a malfunction in this biochemical cascade. These disorders can affect any organ system, producing diverse signs and symptoms, including psychiatric ones. Several authors argue that mitochondrial dysfunction is related to the pathophysiology of bipolar disorder and schizophrenia. Also, the authors retrieved 19 case reports that describe patients with mitochondrial diseases and psychiatric disorders. Most of these patients have psychiatric presentations that preceded the diagnosis of mitochondrial disease. The most common physical findings are fatigue, muscle weakness with or without atrophy, and hearing loss.

Entities:  

Mesh:

Year:  2006        PMID: 16384802     DOI: 10.1176/appi.psy.47.1.1

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  57 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  Cranial Nerve VIII: Hearing and Vestibular Functions.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2010-03

Review 3.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 4.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

5.  The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders.

Authors:  Mari Judit Molnar; Jozsef Perenyi; Eva Siska; George Nemeth; Zoltan Nagy
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

6.  A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.

Authors:  Vanessa F Gonçalves; Carolina Cappi; Christian M Hagen; Adolfo Sequeira; Marquis P Vawter; Andriy Derkach; Clement C Zai; Paula L Hedley; Jonas Bybjerg-Grauholm; Jennie G Pouget; Ari B Cuperfain; Patrick F Sullivan; Michael Christiansen; James L Kennedy; Lei Sun
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

7.  NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.

Authors:  Oded Bergman; Rachel Karry; Jumana Milhem; Dorit Ben-Shachar
Journal:  Mol Psychiatry       Date:  2018-12-10       Impact factor: 15.992

8.  Organochalcogens inhibit mitochondrial complexes I and II in rat brain: possible implications for neurotoxicity.

Authors:  Robson Luiz Puntel; Daniel Henrique Roos; Rodrigo Lopes Seeger; Michael Aschner; João Batista Teixeira Rocha
Journal:  Neurotox Res       Date:  2012-12-06       Impact factor: 3.911

Review 9.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

10.  Effects of omega-3 on behavioral and biochemical parameters in rats submitted to chronic mild stress.

Authors:  Aline Haas de Mello; Aline Gassenferth; Rosiane de Bona Schraiber; Luana da Rosa Souza; Drielly Florentino; Lucinéia Gainski Danielski; Evandro da Cruz Cittadin-Soares; Jucélia Jeremias Fortunato; Fabricia Petronilho; João Quevedo; Gislaine Tezza Rezin
Journal:  Metab Brain Dis       Date:  2014-06-26       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.